Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomized controlled trial - Yusuf, S; Teo, K; Anderson, C (Lancet, 2008)
et al.